DK403086A - Komplex indeholdende cardiotonisk phosphodiesteraseinhibitorer - Google Patents

Komplex indeholdende cardiotonisk phosphodiesteraseinhibitorer Download PDF

Info

Publication number
DK403086A
DK403086A DK403086A DK403086A DK403086A DK 403086 A DK403086 A DK 403086A DK 403086 A DK403086 A DK 403086A DK 403086 A DK403086 A DK 403086A DK 403086 A DK403086 A DK 403086A
Authority
DK
Denmark
Prior art keywords
cardiotonic
complex containing
phosphodiesterase inhibitors
phosphodiesterase
inhibitors
Prior art date
Application number
DK403086A
Other languages
English (en)
Other versions
DK403086D0 (da
Inventor
Eric J Benjamin
Gary C Visor
Original Assignee
Syntex Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Syntex Inc filed Critical Syntex Inc
Publication of DK403086D0 publication Critical patent/DK403086D0/da
Publication of DK403086A publication Critical patent/DK403086A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A61K31/51—Thiamines, e.g. vitamin B1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nutrition Science (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK403086A 1985-08-23 1986-08-22 Komplex indeholdende cardiotonisk phosphodiesteraseinhibitorer DK403086A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76854985A 1985-08-23 1985-08-23

Publications (2)

Publication Number Publication Date
DK403086D0 DK403086D0 (da) 1986-08-22
DK403086A true DK403086A (da) 1987-02-24

Family

ID=25082816

Family Applications (1)

Application Number Title Priority Date Filing Date
DK403086A DK403086A (da) 1985-08-23 1986-08-22 Komplex indeholdende cardiotonisk phosphodiesteraseinhibitorer

Country Status (11)

Country Link
EP (1) EP0212647A3 (da)
JP (1) JPS6284022A (da)
AU (1) AU595826B2 (da)
DK (1) DK403086A (da)
ES (1) ES2001114A6 (da)
FI (1) FI863404A7 (da)
HU (1) HU198395B (da)
IL (1) IL79815A (da)
NO (1) NO863386L (da)
NZ (1) NZ217324A (da)
ZA (1) ZA866388B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0523513A1 (de) 1991-07-05 1993-01-20 Byk Gulden Lomberg Chemische Fabrik GmbH Verwendung substituierter Pyridazine zur Behandlung von Dermatosen

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4189492A (en) * 1977-05-31 1980-02-19 Richardson-Merrell Inc. Antihypertensive compositions of 2-[1-(2,6-dichlorophenoxy)ethyl]-4,5-dihydro-1H-imidazole and N-(2-chloroethyl)-N-(1-methyl-2-phenoxy-ethyl)benzenemethanamine
EP0011828A1 (en) * 1978-11-23 1980-06-11 The Wellcome Foundation Limited Pharmaceutical combinations including hydantoin derivatives, pharmaceutical formulations containing the combinations and methods of making the formulations

Also Published As

Publication number Publication date
HUT41639A (en) 1987-05-28
IL79815A (en) 1990-07-12
ES2001114A6 (es) 1988-04-16
EP0212647A3 (en) 1989-07-19
NZ217324A (en) 1988-06-30
IL79815A0 (en) 1986-11-30
EP0212647A2 (en) 1987-03-04
NO863386L (no) 1987-02-24
FI863404L (fi) 1987-02-24
AU6174686A (en) 1987-02-26
DK403086D0 (da) 1986-08-22
FI863404A0 (fi) 1986-08-22
AU595826B2 (en) 1990-04-12
ZA866388B (en) 1988-04-27
FI863404A7 (fi) 1987-02-24
NO863386D0 (no) 1986-08-22
HU198395B (en) 1989-10-30
JPS6284022A (ja) 1987-04-17

Similar Documents

Publication Publication Date Title
ATE97652T1 (de) Peptidasehemmungsmittel.
IT1215651B (it) Agenti cardiotonici antitrombogenici immidazochinolinici.
FR2581327B1 (fr) Porte-taraud
KR860008823A (ko) 척
DE3674131D1 (de) Substituierte dihalo-statin-reninhemmungsmittel.
DK219986A (da) Nitrogenholdige heterocycliske forbindelser
DK496086D0 (da) Heterocykliske forbindelser
DK540686D0 (da) Cardiotonisk virksomme heterocycliske oxazoloner
FI864597A7 (fi) Kardiotoniska tiazoloner.
DE3664770D1 (de) Cardiotonic quinazoline derivatives
NO860960L (no) Avsetningsinhibitorer.
DK403086D0 (da) Komplex indeholdende cardiotonisk phosphodiesteraseinhibitorer
DK489986A (da) Cardiotoniske aroylthiazoloner
ATA124485A (de) Holster
DK397686A (da) Heterocycliske forbindelser
DK109586D0 (da) Heterocycliske forbindelser
KR860011613U (ko) 가우징 호울더
IE862254L (en) Cardiotonic phosphodiesterase inhibitors complexed with¹vitamins
ES289518Y (es) Porta-cerillas
BR6501062U (pt) Estojo porta-capsulas
SE8505761D0 (sv) Detalj till bankbox
BR6500721U (pt) Conjunto porta-cassetes
BR6502055U (pt) Compasso
BR8501269A (pt) Porta-objetos
IT8535301V0 (it) Morsa reggiprosciutto

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment